目的:系统评价益气活血方治疗缺血性脑卒中的疗效及安全性。方法:计算机检索国内外相关数据库,查找益气活血方药治疗缺血性脑卒中的随机对照试验相关文献,采用Rev Man 5.0软件进行Meta分析。结果:共纳入合格文献27篇,共2 908例患者,其中治疗组1 490例,对照组1 418例。Meta分析结果:益气活血方药或其联合西药常规治疗缺血性脑卒中临床疗效方面与单纯应用西药治疗比较,其差异均有统计学意义[OR=5.39,95%CI（4.03,7.22）,P
摘要(英文)：
This systematic review was aimed to evaluation the effectiveness and safety of supplementingqi and activating blood circulation prescriptions in the treatment of cerebral ischemic stroke. Dtabases both at home and abroad were electronically searched for randomized controlled trials (RCTs) on supplementingqi and activating blood circulation prescriptions in the treatment of cerebral ischemic stroke. And meta-analyses were performed using RevMan 5.0 software. The results showed that 27 studies were included, which contained 2 908 cases. There were 1 490 cases in the treatment group, and 1 418 ca...
